In-vitro activity of LY264826, an investigational glycopeptide antibiotic, against gram-positive bloodstream isolates and selected gram-negative bacilli.
Perl
T M
TM
Wenzel
R P
RP
Jones
R N
RN
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D006094:Gram-Positive Bacteria / Q000187:drug effects*; D016908:Gram-Positive Bacterial Infections / Q000097:blood*; D006801:Humans; D008826:Microbial Sensitivity Tests; D014640:Vancomycin / Q000031:analogs & derivatives* / Q000494:pharmacology
D000900:Anti-Bacterial Agents; C057893:chloroorienticin A; D014640:Vancomycin